EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated mycophenolic acid levels after kidney transplantation: avoiding unnecessary dose reduction through team-based TDM interpretation

Angelika Śmiertka, Agnieszka Cios, Łukasz Hońdo, Agnieszka Supernak, Anna Grzywa, Katarzyna Sobczyńska, Katarzyna Krzanowska, Anna Wesołowska

Folia Medica Cracoviensia · 11.06.2026 · 66 (1) · 123-131

DOI: 10.24425/fmc.2026.158991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Medica Cracoviensia, online erschienen am 11.06.2026. Verfasst von Angelika Śmiertka und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycophenolate mofetil (MMF) is a cornerstone immunosuppressive agent used in combination with calcineurin inhibitors and corticosteroids to prevent acute allograft rejection in solid organ transplant recipients. Long-term transplant outcomes depend not only on the pharmacological efficacy of immunosuppressive regimens but also on individualized dosing strategies and sustained medication adherence. Owing to the complex and highly variable pharmacokinetics of MMF’s active metabolite, mycophenolic acid (MPA), therapeutic drug monitoring (TDM) has become an important tool for optimizing treatment safety andefficacy. We report a case of a kidney transplant recipient with unexpectedly elevated MPA exposure in the absence of clinical toxicity. A detailed pharmacokinetic assessment combined with a comprehensive clinical pharmacist- led medication review indicated that the increased MPA concentrations and elevated AUC0-12h were most likely related to impaired renal elimination of mycophenolic acid glucuronide (MPAG). Reduced MPAG clearance may enhance enterohepatic recirculation (EHR) of MPA, resulting in increased systemic exposure. This case highlights the importance of interpreting elevated MPA concentrations within a broader clinical context and underscores the critical role of clinical pharmacists, as members of an interdisciplinary team, in integrating TDM with comprehensive pharmacokinetic assessment to ensure safe and effective long-term immunosuppressive therapy.

Zitieren

APA

Śmiertka, A., Cios, A., Hońdo, Ł., Supernak, A., Grzywa, A., Sobczyńska, K., Krzanowska, K., & Wesołowska, A. (2026). Elevated mycophenolic acid levels after kidney transplantation: avoiding unnecessary dose reduction through team-based TDM interpretation. Folia Medica Cracoviensia, 66(1), 123-131. https://doi.org/10.24425/fmc.2026.158991

Vancouver

Śmiertka A, Cios A, Hońdo Ł, Supernak A, Grzywa A, Sobczyńska K, et al. Elevated mycophenolic acid levels after kidney transplantation: avoiding unnecessary dose reduction through team-based TDM interpretation. Folia Medica Cracoviensia. 2026;66(1):123-131. doi:10.24425/fmc.2026.158991

BibTeX
@article{miertka2026,
  author = {Śmiertka, Angelika and Cios, Agnieszka and Hońdo, Łukasz and Supernak, Agnieszka and Grzywa, Anna and Sobczyńska, Katarzyna and Krzanowska, Katarzyna and Wesołowska, Anna},
  title = {Elevated mycophenolic acid levels after kidney transplantation: avoiding unnecessary dose reduction through team-based TDM interpretation},
  journal = {Folia Medica Cracoviensia},
  year = {2026},
  volume = {66},
  number = {1},
  pages = {123--131},
  doi = {10.24425/fmc.2026.158991}
}
Kostenlos starten →